Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life
about
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivoPlatelet-derived S100 family member myeloid-related protein-14 regulates thrombosis.A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary cultureBiochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI).Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα.beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activationFeedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2.Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.Fibrinolysis and the control of blood coagulation.Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female miceCarboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?The intrinsic pathway of coagulation: a target for treating thromboembolic disease?Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging.The central role of thrombin in hemostasis.Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XIPlasma and cellular contributions to fibrin network formation, structure and stability.Insights into thrombin activatable fibrinolysis inhibitor function and regulation.In vivo regulation of plasminogen function by plasma carboxypeptidase B.Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice.Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots.Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis.
P2860
Q24623508-45A0F234-34A3-495C-8684-723A4A1E8D09Q28512072-656202A8-78A6-4E1F-BD17-3109F716306CQ28571160-E827E635-1A95-460E-9586-90F380D53059Q33439281-90A92048-9E90-4BAF-8ED3-2AE5E6F40C56Q33640335-30F11AA2-5645-43E4-9BF9-278518456CD3Q33815771-8718B79E-1596-443E-9EFC-9A695365A09DQ34245642-74D168B1-F55D-40FA-B616-8D6CC3DCD010Q34869404-062B09A3-08EC-4B58-88E7-11B84699DD6AQ35008316-7FFFBDE4-2E97-4148-BDE1-D9C5D5EC2C03Q35039847-3DB112E6-62BA-4952-B2DB-0FC043E7DC4DQ35088199-63BF4227-3C96-49DF-810D-1B9BBF524D79Q35159922-6EC8B1E6-CD85-46B0-BBC0-BC191603B9FEQ35208114-F2AE2141-A906-4759-8715-C4CA2B9E6F29Q35642856-B7DE6031-6F9B-4DE5-9485-EEF884B46BBDQ35849691-A3412A89-4A16-42F4-B6AD-680242FB0B67Q35882816-06B566D8-75FB-47ED-BF89-4A18E68B590FQ35903082-A5C90154-8B4A-43E1-8EF5-12F5C943C90AQ36606627-CBEFA344-E98B-48A1-9C90-9D74F974AFE7Q36771762-4074F41E-5E04-4F93-BF3B-E027B2ABA8BEQ36860088-44D8CEB4-DED7-4C33-9E62-67AA2428DE98Q36884335-9FA0A366-DB54-415C-9233-E4E77AAAC421Q37071138-74C254D6-0308-4C4F-96DA-91D3C23A8405Q37768478-6F4251A9-40DF-461F-82BA-3FF6B0FB8D3CQ38117742-8A8A3EDB-43FC-4304-8807-8501D57B4386Q39739972-BAC95A67-C23E-4086-B357-4C9D4BFEC336Q41349130-ADAE6D83-1543-47D8-893D-E761E479808EQ42595647-DEE0507A-874D-45E6-8EFD-844FF104E12CQ42932498-78EEFEE5-D08F-4B79-BF2D-3A2DA3267600Q43188588-D76F71EA-EB53-446F-8CFE-F3F7BC131204Q45168592-CB248DF6-09E0-4B55-9F7C-9AAB1AC5451AQ46910897-2C3F9952-D1BA-48DC-B011-ED050A788EC2
P2860
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Thrombin-activatable fibrinoly ...... is compatible with murine life
@ast
Thrombin-activatable fibrinoly ...... is compatible with murine life
@en
type
label
Thrombin-activatable fibrinoly ...... is compatible with murine life
@ast
Thrombin-activatable fibrinoly ...... is compatible with murine life
@en
prefLabel
Thrombin-activatable fibrinoly ...... is compatible with murine life
@ast
Thrombin-activatable fibrinoly ...... is compatible with murine life
@en
P2093
P2860
P356
P1476
Thrombin-activatable fibrinoly ...... is compatible with murine life
@en
P2093
George J Broze
John Morser
Kathy White
Mariko Nagashima
Meredith Halks-Miller
Nina Lasky
William P Fay
Yanhong Zhu
Zheng-Feng Yin
P2860
P304
P356
10.1172/JCI0212119
P407
P577
2002-01-01T00:00:00Z